MetLife Investment Management’s Claritev Corp CTEV Stock Holding History

MetLife Investment Management’s Portfolio CTEV Stock Details CTEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.1K	Buy	5,211 +376	+8%	+$8.42K	﹤0.01%	2604
2025 Q4	$207K	Hold	4,835	–	–	﹤0.01%	2256
2025 Q3	$257K	Hold	4,835	–	–	﹤0.01%	2179
2025 Q2	$218K	Buy	+4,835	New	+$139K	﹤0.01%	2143
2024 Q2	–	Sell	-3,792	Closed	-$90.3K	–	2927
2024 Q1	$123K	Sell	3,792 -1,318	-26%	-$55.5K	﹤0.01%	2442
2023 Q4	$294K	Hold	5,110	–	–	﹤0.01%	2015
2023 Q3	$343K	Hold	5,110	–	–	﹤0.01%	1857
2023 Q2	$431K	Hold	5,110	–	–	﹤0.01%	1795
2023 Q1	$217K	Buy	5,110 +509	+11%	+$23K	﹤0.01%	2166
2022 Q4	$212K	Sell	4,601 -606	-12%	-$48.4K	﹤0.01%	2214
2022 Q3	$596K	Hold	5,207	–	–	0.01%	1509
2022 Q2	$1.14M	Buy	5,207 +133	+3%	+$26.3K	0.01%	1141
2022 Q1	$950K	Buy	5,074 +1,626	+47%	+$268K	0.01%	1363
2021 Q4	$611K	Buy	3,448 +1,385	+67%	+$247K	0.01%	1404
2021 Q3	$465K	Sell	2,063 -1,571	-43%	-$425K	﹤0.01%	1558
2021 Q2	$1.38M	Buy	+3,634	New	+$1.13M	0.01%	1016

Other funds holding CTEV

HFCIV

H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

ACM

Arini Captial Management London, United Kingdom $634M AUM

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return

BPCM

Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Caspian Capital New York $103M AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

MetLife Investment Management's CTEV Position: Q1 2026 in Review

MetLife Investment Management increased its Claritev Corp (CTEV) stake by 7.8% in Q1 2026, buying an estimated $8.42K and bringing the position to 5,211 shares worth $85.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2604.

MetLife Investment Management first reported a position in CTEV in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.38M in Q2 2021. 94 funds tracked by Wall St. Rank hold CTEV as of Q1 2026.

MetLife Investment Management held 5,211 shares of Claritev Corp worth $85.1K as of Q1 2026.
MetLife Investment Management bought 376 Claritev Corp shares in Q1 2026, an estimated $8.42K.
Claritev Corp made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2604 holding.
MetLife Investment Management first reported a position in Claritev Corp in Q2 2021 and has held it in 16 quarters since.
MetLife Investment Management's Claritev Corp position peaked at $1.38M in Q2 2021.
94 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.